rht.v/rqhtf +.02 to C$1.34 not sure what is happening lately. Been some pressure on the stock. This morning, after the positive pr about new Aussie trial, the price got as low as C$1.16. I bought a few more on the downdraft at C$1.30. It's come all the way back to positive .02 so happy about that. I guess some are getting impatient with the pace of onboarding new patients and the lack of signing big new contracts.
With the hardware problems, I'm guessing Q3 will not be a blockbuster.
But this is a long term play on telemedicine and I think the equipment that can be used to monitor patients has improved and gotten cheap enough to make their vision a practical reality. I've never seen an actual demo of the system reminding a patient to take their pills but that kind of video would be a powerful sellpoint for any adult children with elderly parents that have multiple prescriptions to take. My parents are gone but I vividly remember packing my Dad's pill box for the next two weeks with his 19 pills/day and wondering if he would take them. He also had an early version of remote monitoring. He had a connected scale and he had to use a dialup modem to call in once a day with his weight. He had a congestive heart condition and they were watching for weight gain to reflect water buildup in his system. They also asked him some repetitive questions about how he was feeling. I didn't think it was that effective but that was about 10 years ago.
Now my Google Mini answers many questions for me and I can imagine a connected system of devices could monitor several health conditions fairly effectively. I think the hardware and software have advanced enough to make this practical.
News 
Market Data 
Discover 
AI
